ASCENDIS PHARMA - Trademark Details
Status: 700 - Registered
Serial Number
79225147
Registration Number
6630735
Word Mark
ASCENDIS PHARMA
Status
700 - Registered
Status Date
2022-02-01
Filing Date
2017-10-11
Registration Number
6630735
Registration Date
2022-02-01
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261321, 261709 - Quadrilaterals that are completely or partially shaded. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2021-11-16
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
SHOOR, AMIT KUMAR
Statements
Indication of Colors claimed
The color(s) turquoise, grey, white and blue is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"PHARMA"
Description of Mark
The mark consists of the turquoise word "ASCENDIS" under which is the grey word "PHARMA" next to a polygon broken by a white curved band in which the top is turquoise and the bottom is blue.
Goods and Services
Pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for use in enzyme replacement therapy; pharmaceutical and veterinary preparations, namely, vaccines for the treatment of physical and mental illness; pharmaceutical and veterinary preparations for the treatment of physical and mental illness, namely, pharmaceutical preparations for the prevention and treatment of disorders of the endocrine system, growth hormone deficiencies, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor(FGFR)-related skeletal disorders, oncological disorders, ophthalmologic disorders, infectious diseases, enzyme replacement therapy, anti-inflammatory diseases, pain, respiratory system disorders, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wounds healing, the hormonal system disorders, namely, growth hormone deficiencies, diabetes and angiogenesis, the ophthalmological system disorders, namely, angiogenesis, the angiogenic system disorders, the central nervous system disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, the immune system disorders, namely, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, the cardio-vascular system diseases, the metabolic system disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, the respiratory system, the musculo-skeletal system disorders, namely, growth hormone deficiencies, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, the genitourinary system disorders, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of inflammatory disorders, namely, anti-inflammatories; pharmaceutical preparations for use in dermatology, namely, dermatitis, eczema, psoriasis; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in in ophthalmology pharmaceutical preparations for use in the treatment of gastroenterological disorders; sanitary preparations for medical purposes, namely, sanitizing wipes, disinfectants for medical instruments, adhesive tapes for medical purposes, dietetic foods, namely, dietetic sugar substitutes adapted for medical use, all-purpose disinfectants for sanitary purposes; fungicides, herbicides
Goods and Services
Scientific research within the medical, pharmaceutical and bacteriological area and providing scientific consultancy and information in relation to the aforementioned scientific research, conducting of tests regarding medical applications, namely, conducting clinical trials for others, packaging design, designing and development of medical equipment, designing pharmaceutical and medical preparations, preparation of pharmaceutical formulations, namely, pharmaceutical products development, design and development of granulation technology and tablet technology and providing scientific consultancy and information relating to the design and development of granulation technology and tablet technology
Goods and Services
Licensing of industrial property; legal services
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-19
Primary Code
005
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-01-19
Primary Code
042
International Class
045 - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals. - Personal and social services rendered by others to meet the needs of individuals; security services for the protection of property and individuals.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2018-01-19
Primary Code
045
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktieselskab (a/s)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (aktieselskab (a/s)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (aktieselskab (a/s)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (aktieselskab (a/s)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Eric T. Fingerhut
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1385114
International Registration Date
2017-10-11
International Publication Date
2018-01-18
International Renewal Date
2027-10-11
Auto Protection Date
2019-07-18
International Status
001 - Request for extension of protection established
International Status Date
2018-01-18
Priority Claimed In
True
Priority Claimed Date
2017-06-01
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2018-01-18 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2018-01-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2018-01-19 | ASSIGNED TO EXAMINER |
| 2018-01-23 | APPLICATION FILING RECEIPT MAILED |
| 2018-01-29 | NON-FINAL ACTION WRITTEN |
| 2018-01-30 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2018-02-02 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| 2018-02-06 | NON-FINAL ACTION WRITTEN |
| 2018-02-07 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2018-02-09 | REFUSAL PROCESSED BY MPU |
| 2018-02-09 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2018-03-02 | REFUSAL PROCESSED BY IB |
| 2018-07-24 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2018-07-24 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2018-07-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-08-16 | ASSIGNED TO LIE |
| 2018-08-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-08-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-09-14 | NON-FINAL ACTION WRITTEN |
| 2018-09-14 | NON-FINAL ACTION E-MAILED |
| 2018-09-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2018-09-27 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2018-09-27 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2018-09-28 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2018-10-01 | DATA MODIFICATION COMPLETED |
| 2018-10-19 | SUSPENSION LETTER WRITTEN |
| 2018-10-19 | LETTER OF SUSPENSION E-MAILED |
| 2018-10-19 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| 2019-05-09 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 2019-06-19 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 2019-06-19 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2019-07-05 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 2019-11-21 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| 2020-06-03 | ASSIGNED TO LIE |
| 2020-06-18 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| 2020-09-14 | NON-FINAL ACTION WRITTEN |
| 2020-09-14 | NON-FINAL ACTION E-MAILED |
| 2020-09-14 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2021-03-15 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-03-15 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-03-15 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 2021-03-15 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| 2021-03-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-03-15 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-03-15 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-03-15 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-03-15 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 2021-03-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-03-15 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2021-03-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2021-03-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-03-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-06-10 | ASSIGNED TO EXAMINER |
| 2021-07-09 | FINAL REFUSAL WRITTEN |
| 2021-07-09 | FINAL REFUSAL E-MAILED |
| 2021-07-09 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2021-10-12 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| 2021-10-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2021-10-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2021-10-13 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-10-27 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-10-27 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2021-10-27 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 2021-10-28 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2021-11-16 | PUBLISHED FOR OPPOSITION |
| 2021-11-16 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-11-23 | NOTIFICATION PROCESSED BY IB |
| 2021-12-24 | NEW REPRESENTATIVE AT IB RECEIVED |
| 2022-02-01 | REGISTERED-PRINCIPAL REGISTER |
